430 related articles for article (PubMed ID: 34187430)
1. Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study.
Lu Z; Sun Z; Liu C; Shi X; Li R; Shao W; Zheng Y; Li Y; Song J
BMC Cancer; 2021 Jun; 21(1):751. PubMed ID: 34187430
[TBL] [Abstract][Full Text] [Related]
2. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
Takuma Y; Shota I; Miyatake H; Uematsu S; Okamoto R; Araki Y; Takabatake H; Morimoto Y; Yamamoto H
Intern Med; 2018 Feb; 57(4):457-468. PubMed ID: 29151504
[TBL] [Abstract][Full Text] [Related]
3. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
[TBL] [Abstract][Full Text] [Related]
4. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
[TBL] [Abstract][Full Text] [Related]
7. Construction of web
Zhan G; Cao P; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
[TBL] [Abstract][Full Text] [Related]
8. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.
Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Nomogram for Patients with Hepatocellular Carcinoma After Thermal Ablation.
Ding M; Zhao X; Zhao M; Shi Y; Wang T; Cui D; Shi D; Zhai B
Cardiovasc Intervent Radiol; 2020 Nov; 43(11):1621-1630. PubMed ID: 32814990
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Kim CG; Lee HW; Choi HJ; Lee JI; Lee HW; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim HS; Kim KH; Choi SJ; Kim Y; Lee KS; Kim GM; Kim MD; Won JY; Lee DY; Kim BK
Cancer Med; 2019 Sep; 8(11):5023-5032. PubMed ID: 31290618
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients.
Liu K; Huang G; Chang P; Zhang W; Li T; Dai Z; Lv Y
Sci Rep; 2020 Dec; 10(1):21376. PubMed ID: 33288828
[TBL] [Abstract][Full Text] [Related]
13. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy.
Liu PH; Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
Medicine (Baltimore); 2015 Oct; 94(43):e1808. PubMed ID: 26512576
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
[No Abstract] [Full Text] [Related]
15. Establishment and Verification of a Nomogram for Predicting Survival in Patients with Small Intestinal Gastrointestinal Stromal Tumors.
Lu G; Li J; Wu L; Shi Y; Zhang X; Xia Y; Li L
Dig Dis; 2022; 40(1):50-61. PubMed ID: 33752202
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
17. Development and external validation of prognostic nomograms in hepatocellular carcinoma patients: a population based study.
Xiao Z; Yan Y; Zhou Q; Liu H; Huang P; Zhou Q; Lai C; Zhang J; Wang J; Mao K
Cancer Manag Res; 2019; 11():2691-2708. PubMed ID: 31118768
[No Abstract] [Full Text] [Related]
18. Nomogram predicting survival in patients with lymph node-negative hepatocellular carcinoma based on the SEER database and external validation.
Li Z; Hong Q; Li K
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):904-915. PubMed ID: 38652516
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of Nomograms Predicting Overall and Cancer-Specific Survival of Spinal Chondrosarcoma Patients.
Song K; Song J; Shi X; Wang H; Ma X; Xia X; Liang X; Lin K; Jiang J
Spine (Phila Pa 1976); 2018 Nov; 43(21):E1281-E1289. PubMed ID: 29664813
[TBL] [Abstract][Full Text] [Related]
20. Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection.
Zhao QY; Xie LT; Chen SC; Xu X; Jiang TA; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):532-540. PubMed ID: 33020034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
